Association of visceral fat with cardiopulmonary fitness, oxidative stress and inflammatory markers in asymptomatic individuals with and without family history of type 2 diabetes mellitus

Pravin G Dhone; Goyal Manish; Ekka Abha; Mohd. Mubeen Faheem

doi:10.53730/ijhs.v6nS5.8836

Authors

Dhone Pravin G Professor & Head, Department of Pharmacology, RSDKS GMC, Ambikapur
Goyal Manish Assistant Professor, Department of Physiology, RSDKS GMC, Ambikapur
Ekka Abha Assistant Professor, Department of P.S.M., RSDKS GMC, Ambikapur
Mohd. Mubeen Faheem Associate Professor, Department of Pharmacology, Ayaan Institute of Medical Science Hyderabad

Keywords:

Hyperglycemia, Diabetes Mellitus, Asymptomatic, Polyphagia

Abstract

Diabetes mellitus (DM) is a metabolic disorder characterized by chronic hyperglycemia with derangement of carbohydrate, fat, and protein metabolism due to absolute or relative deficiency of insulin secretion and action, or both. DM, especially type-2 DM, is a serious general medical issue which has arrived at scourge extents because of the quickly expanding paces of this ailment around the world. Target organ confusions, auxiliary to diabetes, are one of the most significant restorative worries of right now. The main findings of our research were no significant differences in baseline characteristics like age and height of both groups. Weight, BMI and waist hip ratio was significantly high in cases. Heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP) and rate pressure product were significantly high in Cases individuals; however, no significant difference was noticed in pulse pressure (PP). Significantly higher body fat and visceral fat %, lower levels of cardio respiratory fitness assess by cooper 12min run test and significantly higher levels of fasting blood sugar (FBS) was observed in cases.

Downloads

Download data is not yet available.

References

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004 May;27(5):1047–53.

Navarro JF, Mora C. Role of inflammation in diabetic complications. Nephrol Dial Transplant. 2005 Dec;20(12):2601–4.

Doi Y, Kiyohara Y, Kubo M, Ninomiya T, Wakugawa Y, Yonemoto K, et al. Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: the Hisayama Study. Diabetes Care. 2005 Oct;28(10):2497–500.

Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes. 2001 Oct;50(10):2384–9.

Leung GM, Lam KS. Diabetic complications and their implications on health care in Asia. Hong Kong Med J. 2000 Mar;6(1):61–8.

Ramakrishna V, Jailkhani R. Evaluation of oxidative stress in Insulin Dependent Diabetes Mellitus (IDDM) patients. Diagn Pathol. 2007;2:22.

Heistad DD. Oxidative stress and vascular disease: 2005 Duff lecture. ArteriosclerThrombVasc Biol. 2006 Apr;26(4):689–95.

Vlassara H, Uribarri J. Advanced Glycation End Products (AGE) and Diabetes: Cause, Effect, or Both? Curr Diab Rep. 2014 Jan;14(1):453.

Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010 Oct 29;107(9):1058–70.

Henriksen EJ, Diamond-Stanic MK, Marchionne EM. Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med. 2011 Sep 1;51(5):993–9.

Leahy JL. Pathogenesis of type 2 diabetes mellitus. Arch Med Res. 2005 Jun;36(3):197–209.

Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet. 1994 Oct 22;344(8930):1105–10.

Kraaijeveld AO, de Jager SCA, van Berkel TJC, Biessen E a. L, Jukema JW. Chemokines and atherosclerotic plaque progression: towards therapeutic targeting? Curr Pharm Des. 2007;13(10):1039–52.

Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn’s disease. Crohn’s Disease cA2 Study Group. N Engl J Med. 1997 Oct 9;337(15):1029–35.

Koster A, Stenholm S, Alley DE, Kim LJ, Simonsick EM, Kanaya AM, et al. Body fat distribution and inflammation among obese older adults with and without metabolic syndrome. Obesity (Silver Spring). 2010 Dec;18(12):2354–61.

Meshkani R, Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem. 2009 Sep;42(13–14):1331–46.

Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993 Jan 1;259(5091):87–91.

Peraldi P, Spiegelman BM. Studies of the mechanism of inhibition of insulin signaling by tumor necrosis factor-alpha. J Endocrinol. 1997 Nov;155(2):219–20.

Indulekha K, Surendar J, Mohan V. High sensitivity C-reactive protein, tumor necrosis factor-α, interleukin-6, and vascular cell adhesion molecule-1 levels in Asian Indians with metabolic syndrome and insulin resistance (CURES-105). J Diabetes Sci Technol. 2011 Jul 1;5(4):982–8.

Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. - PubMed - NCBI [Internet]. [cited 2017 Sep 21].

Fletcher B, Gulanick M, Lamendola C. Risk factors for type 2 diabetes mellitus. J Cardiovasc Nurs. 2002 Jan;16(2):17–23

Erasmus RT, Blanco EB, Okesina AB, Arana JM, Gqweta Z, Matsha T. Importance of family history in type 2 black South African diabetic patients. Postgraduate Medical Journal [Internet]. 2001 May 1 [cited 2019 Oct 3];77(907):323–5. Available from: https://pmj.bmj.com/content/77/907/323

Plagemann A, Harder T, Franke K, Kohlhoff R. Long-term impact of neonatal breast-feeding on body weight and glucose tolerance in children of diabetic mothers. Diabetes Care. 2002 Jan;25(1):16–22.

Crook M. Type 2 diabetes mellitus: a disease of the innate immune system? An update. Diabetic Medicine [Internet]. 2004 [cited 2019 Oct 2];21(3):203–7. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1464-5491.2003.01030.x

Bjørnholt JV, Erikssen G, Liestøl K, Jervell J, Erikssen J, Thaulow E. Prediction of Type 2 diabetes in healthy middle-aged men with special emphasis on glucose homeostasis. Results from 22.5 years’ follow-up. Diabet Med. 2001 Apr;18(4):261–7.

Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A, et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes. 1999 Jan;48(1):150–7.

Hamaguchi K, Kimura A, Kusuda Y, Yamashita T, Yasunami M, Takahasi M, et al. Clinical and genetic characteristics of GAD-antibody positive patients initially diagnosed as having type 2 diabetes. Diabetes Res Clin Pract. 2004 Nov;66(2):163–71.

Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L. Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care. 2000 Apr;23(4):465–71.

Carstens MT, Goedecke JH, Dugas L, Evans J, Kroff J, Levitt NS, et al. Fasting substrate oxidation in relation to habitual dietary fat intake and insulin resistance in non-diabetic women: a case for metabolic flexibility? NutrMetab (Lond). 2013 Jan 14;10(1):8.

Groop L, Forsblom C, Lehtovirta M, Tuomi T, Karanko S, Nissén M, et al. Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes. 1996 Nov;45(11):1585–93.

Florez H, Ryder E, Campos G, Fernandez V, Morales LM, Valbuena H, et al. Women relatives of Hispanic patients with type 2 diabetes are more prone to exhibit metabolic disturbances. Invest Clin. 1999 Jun;40(2):127–42.

Gravante G, Pomara F, Angelomè C, Russo G, Truglio G. The basal energy expenditure of female athletes vs. sedentary women as related to their family history of type 2 diabetes. Acta Diabetol. 2001;38(2):63–70.

Tequeanes ALL, Fabián MG, Plata M del RF, Sancho MCG. Estudiometabólico de los familiares de pacientes con diabetes tipo 2. Med Int Mex [Internet]. 2011 [cited 2019 Oct 3];27(1):5–10. Available from: https://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDARTICULO=28462

Olive JL, Ballard KD, Miller JJ, Milliner BA. Metabolic rate and vascular function are reduced in women with a family history of type 2 diabetes mellitus. Metab Clin Exp. 2008 Jun;57(6):831–7.